Figure Weight Loss

Figure Weight Loss has served patients in Edgewood, Kentucky and surrounding regions since 1999, building a practice centered on evidence-based obesity medicine and metabolic health. The clinic's physicians hold certification from the American Board of Obesity Medicine, bringing over two decades of clinical experience in medical weight management to patients across Kentucky, Ohio, Indiana, Tennessee, and Michigan through both in-person consultations at their Northern Kentucky location and comprehensive telehealth services. This dual-access model allows patients to receive board-certified obesity medicine care regardless of geographic constraints, with the same clinical rigor applied to virtual and in-office visits.

The clinic's pharmacological approach features FDA-approved GLP-1 receptor agonists including semaglutide and liraglutide, medications that work by mimicking incretin hormones to regulate appetite and glucose metabolism. Semaglutide, administered as a once-weekly subcutaneous injection, has demonstrated significant weight reduction in clinical trials by slowing gastric emptying and reducing hunger signals at the hypothalamic level. Liraglutide operates through similar mechanisms with daily dosing, providing an alternative for patients who prefer more frequent administration or have specific metabolic profiles that respond better to this formulation. These peptide-based medications are integrated into comprehensive programs that address the multifactorial nature of obesity, rather than offered as standalone prescriptions. The clinic's protocols combine medication management with structured nutrition counseling delivered by registered dietitians who create individualized meal frameworks based on patient metabolic data, food preferences, and lifestyle constraints.

Figure Weight Loss employs a collaborative care model where board-certified obesity medicine physicians work alongside registered dietitians and nursing staff to deliver coordinated treatment. Patients receive initial comprehensive metabolic assessments that inform medication selection and dosing strategies, followed by regular monitoring appointments to track response and adjust protocols. The nursing team conducts routine check-ins to assess medication tolerance, address injection technique questions for patients using semaglutide or liraglutide, and provide accountability between physician visits. Dietitians deliver ongoing nutrition education that extends beyond calorie restriction to address macronutrient timing, sustainable eating patterns, and behavioral strategies for long-term weight maintenance. For appropriate candidates, the clinic also offers hormone replacement therapy (HRT) when hormonal imbalances contribute to weight gain or impede weight loss efforts, particularly in perimenopausal and menopausal women or men with clinically low testosterone.

Patients beginning treatment at Figure Weight Loss undergo an initial consultation that includes medical history review, current medication assessment, metabolic screening, and discussion of weight loss goals and previous attempts. This evaluation determines candidacy for GLP-1 medications and identifies any contraindications or comorbidities requiring modified approaches. Following treatment initiation, patients attend scheduled follow-up appointments where providers review weight trends, assess medication side effects, and modify dosing as needed to optimize results while minimizing gastrointestinal symptoms common during GLP-1 therapy titration. The dietitian component includes education on protein prioritization to preserve lean muscle mass during weight reduction, strategies for managing the appetite suppression effects of semaglutide and liraglutide, and practical meal planning tools that patients can implement in real-world settings. The clinic provides educational resources and structured frameworks rather than rigid meal plans, recognizing that sustainable weight management requires adaptable strategies that fit individual lifestyles.

The telehealth platform extends Figure Weight Loss services across five states, allowing patients in rural areas or those with scheduling constraints to access board-certified obesity medicine care without travel requirements. Virtual visits replicate the comprehensive approach of in-office appointments, with providers reviewing uploaded progress photos, discussing medication experiences, and adjusting treatment plans through secure video consultations. Prescriptions for semaglutide and liraglutide are sent electronically to patients' preferred pharmacies, and the nursing team remains available for between-visit questions through patient portal messaging. This accessibility has proven particularly valuable for patients managing obesity alongside demanding work schedules or mobility limitations. With nearly 1,800 patient reviews averaging 4.9 stars, the clinic has established a reputation for delivering structured, educational weight loss programs that equip patients with both pharmacological tools and practical knowledge for long-term metabolic health management in Edgewood and throughout the multi-state telehealth service area.